Zydus Wellness · NSE: ZYDUSWELL · BSE: 531335
Q2 FY20 results · Jul–Sep 2019
Zydus Wellness reported revenue from operations of ₹326.03 crore (up 135.9% from Q2 FY19) and net loss of ₹12.02 crore for Q2 FY20 (Jul–Sep 2019), on a consolidated basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 326.03 | 138.21 | +135.9% | 620.25 | −47.4% |
| Other income | 3.95 | 10.20 | −61.3% | 3.03 | +30.4% |
| Total income | 329.98 | 148.41 | +122.3% | 623.28 | −47.1% |
| Profit before tax | (14.58) | 46.17 | Turned loss | 79.84 | Turned loss |
| Net profit for the period | (12.02) | 42.16 | Turned loss | 80.40 | Turned loss |
| Attributable to shareholders of the company | (11.83) | 41.41 | Turned loss | — | — |
| EPS, basic (₹) | (2.09) | 10.60 | not comparable | 13.95 | Turned loss |
| Net margin (%) | -3.7 | 30.5 | 13.0 |
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 39.63 | 75.00 | −47.2% | 36.92 | +7.3% |
| Other income | 26.61 | 10.03 | +165.3% | 26.05 | +2.1% |
| Total income | 66.24 | 85.03 | −22.1% | 62.97 | +5.2% |
| Profit before tax | (12.66) | 41.03 | Turned loss | (18.86) | Loss narrowed |
| Net profit for the period | (12.48) | 41.10 | Turned loss | (18.76) | Loss narrowed |
| EPS, basic (₹) | (2.16) | 10.52 | not comparable | (3.25) | Loss narrowed |
| Net margin (%) | -31.5 | 54.8 | -50.8 |
Consolidated
- Filed with BSE
- 13 Nov 2019, 17:31 IST
- Board meeting
- 13 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Nov 2019, 17:31 IST
- Board meeting
- 13 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE